Blonder Tongue Laboratories (BDRLQ) Ratios

202 Followers

Blonder Tongue Laboratories Ratios

BDRLQ's free cash flow for Q1 2025 was $0.34. For the 2025 fiscal year, BDRLQ's free cash flow was decreased by $ and operating cash flow was $-0.04. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Mar 22
Liquidity Ratios
Current Ratio	0.60	0.60	0.75	0.98	1.27
Quick Ratio	0.26	0.26	0.30	0.49	0.47
Cash Ratio	<0.01	<0.01	<0.01	<0.01	0.05
Solvency Ratio	-0.04	-0.04	-0.11	-0.15	0.14
Operating Cash Flow Ratio	0.16	0.16	0.31	-0.17	-0.19
Short-Term Operating Cash Flow Coverage	0.40	0.31	0.63	-0.27	-0.35
Net Current Asset Value	$ -7.38M	$ -7.38M	$ -7.07M	$ -5.96M	$ -947.00K
Leverage Ratios
Debt-to-Assets Ratio	0.86	0.86	0.82	1.03	0.67
Debt-to-Equity Ratio	-4.71	-4.71	-17.69	14.40	2.42
Debt-to-Capital Ratio	1.27	1.27	1.06	0.94	0.71
Long-Term Debt-to-Capital Ratio	6.40	6.40	1.36	0.84	0.44
Financial Leverage Ratio	-5.45	-5.45	-21.65	13.97	3.63
Debt Service Coverage Ratio	0.13	0.10	-0.10	-0.21	0.46
Interest Coverage Ratio	-0.81	-0.81	-1.45	-2.70	-5.76
Debt to Market Cap	1.60K	3.95	4.54	4.25	0.82
Interest Debt Per Share	0.62	0.62	0.72	1.22	0.70
Net Debt to EBITDA	18.13	18.13	-22.53	-12.41	4.38
Profitability Margins
Gross Profit Margin	33.18%	33.18%	30.11%	30.16%	37.18%
EBIT Margin	-3.56%	-3.56%	-9.37%	-11.76%	3.89%
EBITDA Margin	4.00%	4.00%	-3.11%	-6.85%	11.13%
Operating Profit Margin	-6.11%	-6.11%	-9.52%	-11.76%	-18.79%
Pretax Profit Margin	-11.07%	-11.07%	-15.93%	-16.12%	0.63%
Net Profit Margin	-11.18%	-11.18%	-16.02%	-16.12%	0.53%
Continuous Operations Profit Margin	-11.18%	-11.18%	-16.02%	-16.12%	0.53%
Net Income Per EBT	100.97%	100.97%	100.57%	100.00%	84.85%
EBT Per EBIT	181.23%	181.23%	167.33%	137.02%	-3.34%
Return on Assets (ROA)	-13.24%	-13.24%	-18.66%	-19.46%	0.71%
Return on Equity (ROE)	110.79%	72.18%	404.01%	-271.88%	2.56%
Return on Capital Employed (ROCE)	-21.96%	-21.96%	-25.51%	-31.11%	-50.60%
Return on Invested Capital (ROIC)	-10.64%	-10.64%	-14.39%	-17.12%	-25.01%
Return on Tangible Assets	-15.23%	-15.23%	-20.94%	-21.21%	0.79%
Earnings Yield	-43225.27%	-91.97%	-185.63%	-114.75%	1.17%
Efficiency Ratios
Receivables Turnover	7.28	7.28	8.59	5.35	8.93
Payables Turnover	3.62	3.62	4.65	5.20	4.37
Inventory Turnover	3.46	3.46	3.22	3.19	2.04
Fixed Asset Turnover	2.79	2.79	2.73	3.61	54.32
Asset Turnover	1.18	1.18	1.16	1.21	1.32
Working Capital Turnover Ratio	-5.35	-5.35	-14.62	25.34	14.40
Cash Conversion Cycle	54.80	54.80	77.27	112.57	136.42
Days of Sales Outstanding	50.15	50.15	42.49	68.29	40.89
Days of Inventory Outstanding	105.54	105.54	113.29	114.42	179.03
Days of Payables Outstanding	100.89	100.89	78.50	70.13	83.50
Operating Cycle	155.69	155.69	155.77	182.70	219.93
Cash Flow Ratios
Operating Cash Flow Per Share	0.07	0.07	0.14	-0.10	-0.10
Free Cash Flow Per Share	0.07	0.07	0.10	-0.11	-0.10
CapEx Per Share	<0.01	<0.01	0.05	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	1.00	1.00	0.67	1.04	1.07
Dividend Paid and CapEx Coverage Ratio	259.75	259.75	3.07	-25.13	-13.57
Capital Expenditure Coverage Ratio	259.75	259.75	3.07	-25.13	-13.57
Operating Cash Flow Coverage Ratio	0.13	0.13	0.21	-0.09	-0.15
Operating Cash Flow to Sales Ratio	0.09	0.09	0.15	-0.08	-0.07
Free Cash Flow Yield	35763.65%	76.27%	117.67%	-56.47%	-17.48%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	>-0.01	-1.09	-0.54	-0.87	85.35
Price-to-Sales (P/S) Ratio	<0.01	0.12	0.09	0.14	0.46
Price-to-Book (P/B) Ratio	>-0.01	-0.78	-2.18	2.37	2.18
Price-to-Free Cash Flow (P/FCF) Ratio	<0.01	1.31	0.85	-1.77	-5.72
Price-to-Operating Cash Flow Ratio	<0.01	1.31	0.57	-1.84	-6.14
Price-to-Earnings Growth (PEG) Ratio	>-0.01	0.03	0.02	<0.01	-0.85
Price-to-Fair Value	>-0.01	-0.78	-2.18	2.37	2.18
Enterprise Value Multiple	18.14	21.17	-25.30	-14.46	8.46
Enterprise Value	8.11M	9.46M	10.40M	17.93M	14.85M
EV to EBITDA	18.14	21.17	-25.30	-14.46	8.46
EV to Sales	0.73	0.85	0.79	0.99	0.94
EV to Free Cash Flow	7.83	9.14	7.75	-12.48	-11.85
EV to Operating Cash Flow	7.80	9.11	5.23	-12.97	-12.72
Tangible Book Value Per Share	-0.21	-0.21	-0.13	-0.01	0.17
Shareholders’ Equity Per Share	-0.12	-0.12	-0.04	0.08	0.27
Tax and Other Ratios
Effective Tax Rate	>-0.01	>-0.01	>-0.01	0.00	0.15
Revenue Per Share	0.77	0.77	0.94	1.36	1.30
Net Income Per Share	-0.09	-0.09	-0.15	-0.22	<0.01
Tax Burden	1.01	1.01	1.01	1.00	0.85
Interest Burden	3.11	3.11	1.70	1.37	0.16
Research & Development to Revenue	0.10	0.10	0.10	0.10	0.16
SG&A to Revenue	0.29	0.29	0.20	0.21	0.24
Stock-Based Compensation to Revenue	<0.01	<0.01	0.02	0.03	0.04
Income Quality	-0.83	-0.83	-0.94	0.47	-13.89

Currency in USD